Reading IIEF Scores in Male Supplement Studies: How to Judge Claims About the Best Male Enhancement Pills That Work

Why one questionnaire sits underneath almost every claim

If you trace a men's supplement claim back far enough, you usually arrive at the International Index of Erectile Function. It was developed in the late 1990s as an outcome measure for clinical trials, and it became the standard because it was validated across languages and populations and because regulators accepted it. Almost every serious study in this space uses it or its shortened five-item version, the IIEF-5, sometimes called the Sexual Health Inventory for Men.

That ubiquity is useful. It means results from different studies can be compared on a common scale, and it means a marketing page quoting "an improvement" can be checked against a known metric rather than against a feeling. It also means anyone who understands the scale can spot when a claim has been stretched. Learning to read IIEF numbers is the single highest-leverage skill for evaluating this category, more useful than memorising ingredient lists. It is also the fastest way to see through a ranking, and our account of how ranked lists of men's pills get built explains why those league tables so rarely rest on numbers like these.

The full IIEF contains fifteen questions grouped into five domains: erectile function, orgasmic function, sexual desire, intercourse satisfaction and overall satisfaction. The erectile function domain carries six of those questions and is scored from 6 to 30. When a study reports "IIEF improved", it should say which domain and by how many points. If it does not, that is your first warning.

What the numbers actually mean on the scale

Score bands on the erectile function domain are conventionally described in ranges, with lower totals indicating more severe difficulty and totals in the mid-to-high twenties considered within a normal range. The exact cut-points differ slightly between publications, which is itself worth knowing: a study that reclassifies men into a "normal" band may have moved them across a boundary by two points, not transformed anyone's life.

The concept that matters most here is the minimal clinically important difference, or MCID. It is the smallest change on an instrument that a patient would recognise as a real improvement rather than statistical noise. For the IIEF erectile function domain, the MCID is commonly described as around four points, with the exact figure varying by baseline severity — men who start lower generally need a larger absolute change to notice it.

This gives you a practical filter. When a claim rests on a two-point move, the honest description is "measurable in the data, below the threshold researchers use for meaningfulness". That is not nothing, and in a supplement context it may still be a genuine signal. It is simply not the same as the transformation the copy implies.

The four questions that separate a real result from a headline

When you meet an IIEF claim, four questions resolve most of the ambiguity quickly.

Which domain? The erectile function domain is the demanding one. Desire and overall satisfaction are softer, more mood-sensitive domains, and a gain there is easier to produce. Marketing that says "IIEF score improved" without naming the domain has usually chosen the easiest one.

Compared with what? A single-arm study in which everyone takes the product and the score rises tells you almost nothing, because placebo effects in sexual health research are famously large. The only informative comparison is against a matched placebo group over the same period.

How many men, for how long? Twenty participants over four weeks produces a fragile result no matter how good it looks. Effects that survive in larger groups over three months are worth more than dramatic effects in tiny ones.

Who paid? Industry funding does not invalidate a study, but it changes how much independent replication you should want before treating the finding as settled. The most honest papers state their funding source plainly in the first page.

A two-point IIEF gain over placebo in forty men across eight weeks is a modest, interesting signal. Written as "a 12% improvement in sexual function", the same number becomes a headline. Nothing in the data changed; only the framing did.

How claims about the best male enhancement pills that work get built from small numbers

The gap between a paper and a sales page is usually built with four familiar moves, and none of them requires anyone to lie outright. Percentages replace points, because a percentage of a low baseline looks bigger. The placebo arm disappears from the summary, because the absolute rise in the active group is larger than the difference between arms. A soft domain is quoted while the erectile function domain is omitted. And an ingredient study becomes a product claim, even though the finished blend was never tested.

Once you can see those four moves, most of the noise in the category resolves. Shoppers hunting for the best male enhancement pills that work can then evaluate a page in about a minute: find the number, find the domain, find the comparison group, find the sample size. If any of the four is missing, the claim is decorative. This is also the fastest way to compare products advertised as best male enhancement pills for stamina, where the outcome measures are often borrowed from exercise research rather than sexual health research and are not interchangeable.

For the ingredient side of that same evaluation, our evidence-tier ranking of male vitality ingredients sorts the actives by how much human data stands behind each one, and the Steel Power ingredient breakdown shows how one formula lines up against those tiers.

IIEF at a glance: domains, ranges and what a change is worth

The table below is the reference to keep in mind when a study or a sales page quotes a number.

Domain or version	Items	Score range	How to read a change
Erectile function domain	6	6–30	Strongest measure; about four points before it is considered clinically important
Orgasmic function	2	0–10	Narrow range, so small point moves look proportionally large
Sexual desire	2	2–10	Highly mood-sensitive; strongly affected by expectation
Intercourse satisfaction	3	0–15	Depends on partner and frequency, not only on the participant
Overall satisfaction	2	2–10	The softest domain; easiest place to produce a positive number
IIEF-5 short form	5	5–25	Screening tool; convenient but less granular than the full index

One structural point explains a lot of the confusion around these scores: the IIEF measures erectile and sexual function, not hormone status, so it is the right instrument for circulation-focused products and the wrong one for hormonal ones. That distinction is the whole subject of male enhancement pills versus testosterone boosters, and the tolerability side of the same trials is covered in testosterone booster side effects explained.

What the IIEF cannot do

The instrument has real limits, and reading it well means holding them in mind.

It is entirely self-reported. Nothing in the IIEF is measured by a device or a blood test. It records what a man remembers and chooses to report about the previous four weeks, which means memory, mood, relationship context and expectation all get folded into the score. That is not a flaw in the design — the experience is the outcome that matters — but it is why an uncontrolled study is close to uninterpretable.

It assumes recent sexual activity. Several items ask about attempts at intercourse in the last four weeks. Men without a partner, or with an inactive period for unrelated reasons, score lower for reasons that have nothing to do with function, which distorts small samples in particular.

It measures function, not cause. A low score is a signal, not a diagnosis. The underlying reason might be vascular, hormonal, neurological, psychological or a side effect of medication, and those have completely different answers. This is the point at which a supplement page should stop and a clinician should start. Mayo Clinic and the NIH both publish plain-language explanations of when erectile difficulty warrants medical assessment, and persistent symptoms belong in that conversation rather than in a shopping cart.

It cannot be used to claim a supplement treats anything. Dietary supplements are not permitted to claim they treat, cure or prevent erectile dysfunction, and no IIEF number changes that. The legitimate framing is support for normal circulation, energy and vitality — which is a narrower claim than most advertising makes. The vocabulary used to blur that line is worth knowing in detail, and we take it apart in what “proven” really means in men’s supplement marketing.

Frequently asked questions